Literature DB >> 17373976

Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.

J C Szepietowski1, A Reich, P Pacan, E Garlowska, E Baran.   

Abstract

BACKGROUND: Onychomycosis is the most frequent nail disease, which could impair the patient's quality of life.
OBJECTIVE: The present study was undertaken to evaluate the impact of toenail onychomycosis on quality of life among Polish population. PATIENTS AND METHODS: Three thousand nine-hundred and four (3904: 2269 females and 1635 males) individuals fulfilled an international onychomycosis-specific quality-of-life questionnaire consisting of statements regarding social, emotional and symptoms problems. All patients had toenail onychomycosis confirmed by the positive direct microscopic examination and/or by the positive mycologic culture. Seven hundred and sixty-seven patients simultaneously had fingernail onychomycosis. All patients were divided into subgroups according to sex, age, education level, place of living, type of onychomycosis, number of involved toenails, fingernails involvement, duration of illness and previously used antimycotic therapy.
RESULTS: Most of the patients demonstrated significantly reduced quality of life. The degree of life impairment varied between analysed subgroups. Patients with more advanced toenail onychomycosis and with fingernail involvement were more seriously affected. Both social and emotional impairments were more pronounced in female than in male patients, although there were no differences according to symptoms. Moreover, patients with better educational level and people living in towns or cities were more emotionally and socially affected by onychomycosis, although people living in the country or with poorer education level presented with significantly more severe symptoms.
CONCLUSIONS: Toenail onychomycosis is still a serious medical problem, which can significantly reduce the patient's quality of life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373976     DOI: 10.1111/j.1468-3083.2006.02004.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

Review 1.  Patient-Reported Outcomes in Onychomycosis: A Review of Psychometrically Evaluated Instruments in Assessing Treatment Effectiveness.

Authors:  Jenny Wang; Lauren E Wiznia; Evan A Rieder
Journal:  Skin Appendage Disord       Date:  2017-04-21

2.  Penetration of ((14)C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish.

Authors:  Joshua A Zeichner; Linda Stein Gold; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

3.  The influence of superficial dermatophytoses epidemic in India on patients' quality of life.

Authors:  Shyam Verma; Resham Vasani; Radomir Reszke; Lukasz Matusiak; Jacek C Szepietowski
Journal:  Postepy Dermatol Alergol       Date:  2019-11-27       Impact factor: 1.837

4.  Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life.

Authors:  Antonella Tosti; Bom E Elewski
Journal:  J Clin Aesthet Dermatol       Date:  2014-11

Review 5.  The Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature.

Authors:  Aditya K Gupta; Rachel R Mays
Journal:  Skin Appendage Disord       Date:  2018-02-13

6.  The Effect of Q-Switched Nd:YAG 1064 nm/532 nm Laser in the Treatment of Onychomycosis In Vivo.

Authors:  Kostas Kalokasidis; Meltem Onder; Myrto-Georgia Trakatelli; Bertrand Richert; Klaus Fritz
Journal:  Dermatol Res Pract       Date:  2013-12-14

7.  The Impact of Onychopathies on Quality of Life: A Hospital-based, Cross-sectional Study.

Authors:  Hera Tabassum; Mohammad Adil; Syed S Amin; Mohd Mohtashim; Roopal Bansal; Divya Agrawal
Journal:  Indian Dermatol Online J       Date:  2020-03-09

8.  More than Nail Deep: The Effect of Efinaconazole 10% Treatment on the Quality of Life in Patients with Onychomycosis: A post hoc Study.

Authors:  Aditya K Gupta; Maanasa Venkataraman; Emma M Quinlan; Madhulika A Gupta; Naveen Anbalagan; Rachel Lyons
Journal:  Skin Appendage Disord       Date:  2021-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.